[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fLtbTmf7DSZYACWnVCjs8tDFVwPxVPL9cC228Sys3MuU":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":38,"phaseBuckets":49,"rows":56},"Riphah International University",[4],2017,false,470,0,106632,3,1998,[14,17,20,23,26,29,32,35],{"name":15,"count":16},"Stroke",129,{"name":18,"count":19},"Sports Physical Therapy",98,{"name":21,"count":22},"Cerebral Palsy",66,{"name":24,"count":25},"Neck Pain",63,{"name":27,"count":28},"Low Back Pain",59,{"name":30,"count":31},"Knee Osteoarthritis",56,{"name":33,"count":34},"Down Syndrome",38,{"name":36,"count":37},"Adhesive Capsulitis",28,[39,44],{"nctId":40,"briefTitle":41,"date":42,"intervention":43},"NCT06762262","Effects of Pilate Training Versus Moderate Intensity Continous Training in Hypertensive Patients","2024-12-30","Moderate-Intensity continuous training",{"nctId":45,"briefTitle":46,"date":47,"intervention":48},"NCT07448844","Intralesional Therapies For Cutaneous Viral Warts: A Comparative Analysis Of Vitamin D3 And Acyclovir","2026-05-20","Intralesional Acyclovir",[50,51,52,53,54,55],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[57,88,106,129,155,191,225,250,274,292,320,338,356,380,406,434,452,478,496,522,540,564,582,607,633,651],{"intervention":48,"totalTrials":58,"cells":59},1,{"EARLY_PHASE1":60,"PHASE1":62,"PHASE2":64,"PHASE3":66,"PHASE4":68,"NA":86},{"trials":61,"activeCount":9},[],{"trials":63,"activeCount":9},[],{"trials":65,"activeCount":9},[],{"trials":67,"activeCount":9},[],{"trials":69,"activeCount":58,"soonestReadout":47},[70],{"nctId":45,"briefTitle":46,"status":71,"phases":72,"primaryCompletion":47,"completion":47,"start":73,"enrollment":74,"conditions":75,"interventions":84},"RECRUITING",[54],"2026-02-20",40,[76,77,78,79,80,81,82,83],"Viral Wart","Plantar Wart","Common Warts (Verruca Vulgaris)","Common Wart","Flat Wart","Warts of Foot","Warts Hand","Wart",[48,85],"Intralesional Vitamin D3",{"trials":87,"activeCount":9},[],{"intervention":85,"totalTrials":58,"cells":89},{"EARLY_PHASE1":90,"PHASE1":92,"PHASE2":94,"PHASE3":96,"PHASE4":98,"NA":104},{"trials":91,"activeCount":9},[],{"trials":93,"activeCount":9},[],{"trials":95,"activeCount":9},[],{"trials":97,"activeCount":9},[],{"trials":99,"activeCount":58,"soonestReadout":47},[100],{"nctId":45,"briefTitle":46,"status":71,"phases":101,"primaryCompletion":47,"completion":47,"start":73,"enrollment":74,"conditions":102,"interventions":103},[54],[76,77,78,79,80,81,82,83],[48,85],{"trials":105,"activeCount":9},[],{"intervention":43,"totalTrials":58,"cells":107},{"EARLY_PHASE1":108,"PHASE1":110,"PHASE2":112,"PHASE3":114,"PHASE4":116,"NA":118},{"trials":109,"activeCount":9},[],{"trials":111,"activeCount":9},[],{"trials":113,"activeCount":9},[],{"trials":115,"activeCount":9},[],{"trials":117,"activeCount":9},[],{"trials":119,"activeCount":58,"soonestReadout":42},[120],{"nctId":40,"briefTitle":41,"status":121,"phases":122,"primaryCompletion":42,"completion":123,"start":124,"enrollment":125,"conditions":126,"interventions":128},"ACTIVE_NOT_RECRUITING",[55],"2025-04-30","2024-04-20",52,[127],"Prehypertension",[43],{"intervention":130,"totalTrials":58,"cells":131},"Surface Electrical Stimulation",{"EARLY_PHASE1":132,"PHASE1":134,"PHASE2":147,"PHASE3":149,"PHASE4":151,"NA":153},{"trials":133,"activeCount":9},[],{"trials":135,"activeCount":9},[136],{"nctId":137,"briefTitle":138,"status":139,"phases":140,"primaryCompletion":141,"completion":141,"start":142,"enrollment":143,"conditions":144,"interventions":146},"NCT06840938","Physiological Manipulation and Surface Electrical Stimulation in Post Stroke Dysphagia Patients","COMPLETED",[51],"2025-12-05","2025-04-01",158,[145],"Dysphagia Following Cerebrovascular Accident",[130],{"trials":148,"activeCount":9},[],{"trials":150,"activeCount":9},[],{"trials":152,"activeCount":9},[],{"trials":154,"activeCount":9},[],{"intervention":156,"totalTrials":157,"cells":158},"Atorvastatin",2,{"EARLY_PHASE1":159,"PHASE1":161,"PHASE2":163,"PHASE3":165,"PHASE4":167,"NA":169},{"trials":160,"activeCount":9},[],{"trials":162,"activeCount":9},[],{"trials":164,"activeCount":9},[],{"trials":166,"activeCount":9},[],{"trials":168,"activeCount":9},[],{"trials":170,"activeCount":9},[171,181],{"nctId":172,"briefTitle":173,"status":139,"phases":174,"primaryCompletion":175,"completion":175,"start":176,"enrollment":177,"conditions":178,"interventions":180},"NCT07148037","Effect of SLC01B1 (rs4149956) Polymorphism on the Efficacy and Tolerability of Atorvastatin in Pakistani Population",[],"2025-07-31","2024-09-01",150,[179],"Hyperlipidemias",[156],{"nctId":182,"briefTitle":183,"status":139,"phases":184,"primaryCompletion":185,"completion":186,"start":187,"enrollment":188,"conditions":189,"interventions":190},"NCT06674044","Effect of SLC01B1 (rs2306283) Polymorphism on the Efficacy and Safety Profile of Atorvastatin in Pakistani Population",[],"2024-07-31","2024-08-31","2023-12-01",100,[179],[156],{"intervention":192,"totalTrials":157,"cells":193},"conventional treatment",{"EARLY_PHASE1":194,"PHASE1":196,"PHASE2":198,"PHASE3":200,"PHASE4":202,"NA":204},{"trials":195,"activeCount":9},[],{"trials":197,"activeCount":9},[],{"trials":199,"activeCount":9},[],{"trials":201,"activeCount":9},[],{"trials":203,"activeCount":9},[],{"trials":205,"activeCount":9},[206,217],{"nctId":207,"briefTitle":208,"status":139,"phases":209,"primaryCompletion":210,"completion":211,"start":212,"enrollment":213,"conditions":214,"interventions":215},"NCT05084820","Action Observation Treatment on Motor Function in Upper Limb of Patients With Chronic Stroke",[55],"2021-07-15","2021-08-15","2020-10-15",14,[15],[216,192],"Action observation treatment",{"nctId":218,"briefTitle":219,"status":139,"phases":220,"primaryCompletion":210,"completion":211,"start":212,"enrollment":74,"conditions":221,"interventions":223},"NCT05087719","Effects of Proprioceptive Activities on Hand Function in Chronic Stroke Patients",[55],[15,222],"Proprioceptive Disorders",[224,192],"experimental group",{"intervention":226,"totalTrials":58,"cells":227},"pursed lip breathing",{"EARLY_PHASE1":228,"PHASE1":230,"PHASE2":232,"PHASE3":234,"PHASE4":236,"NA":238},{"trials":229,"activeCount":9},[],{"trials":231,"activeCount":9},[],{"trials":233,"activeCount":9},[],{"trials":235,"activeCount":9},[],{"trials":237,"activeCount":9},[],{"trials":239,"activeCount":9},[240],{"nctId":241,"briefTitle":242,"status":139,"phases":243,"primaryCompletion":187,"completion":244,"start":245,"enrollment":246,"conditions":247,"interventions":249},"NCT06196957","Effect of Senobi Versus Buteyko Technique on Functional Performance of Chronic Obstructive Pulmonary Disease Patient.",[55],"2023-12-10","2023-07-20",32,[248],"Shortness of Breath",[226],{"intervention":251,"totalTrials":58,"cells":252},"M1 + Cerebellar Stimulation Group",{"EARLY_PHASE1":253,"PHASE1":255,"PHASE2":257,"PHASE3":259,"PHASE4":261,"NA":263},{"trials":254,"activeCount":9},[],{"trials":256,"activeCount":9},[],{"trials":258,"activeCount":9},[],{"trials":260,"activeCount":9},[],{"trials":262,"activeCount":9},[],{"trials":264,"activeCount":9},[265],{"nctId":266,"briefTitle":267,"status":139,"phases":268,"primaryCompletion":269,"completion":269,"start":270,"enrollment":125,"conditions":271,"interventions":273},"NCT06757088","Combined Effects of Transcranial Direct Current Stimulation on Postural Control in Elderly",[55],"2025-02-15","2024-10-15",[272],"Postural; Defect",[251],{"intervention":216,"totalTrials":58,"cells":275},{"EARLY_PHASE1":276,"PHASE1":278,"PHASE2":280,"PHASE3":282,"PHASE4":284,"NA":286},{"trials":277,"activeCount":9},[],{"trials":279,"activeCount":9},[],{"trials":281,"activeCount":9},[],{"trials":283,"activeCount":9},[],{"trials":285,"activeCount":9},[],{"trials":287,"activeCount":9},[288],{"nctId":207,"briefTitle":208,"status":139,"phases":289,"primaryCompletion":210,"completion":211,"start":212,"enrollment":213,"conditions":290,"interventions":291},[55],[15],[216,192],{"intervention":293,"totalTrials":58,"cells":294},"1ml of 1% metronidazole gel",{"EARLY_PHASE1":295,"PHASE1":297,"PHASE2":299,"PHASE3":301,"PHASE4":303,"NA":305},{"trials":296,"activeCount":9},[],{"trials":298,"activeCount":9},[],{"trials":300,"activeCount":9},[],{"trials":302,"activeCount":9},[],{"trials":304,"activeCount":9},[],{"trials":306,"activeCount":9},[307],{"nctId":308,"briefTitle":309,"status":139,"phases":310,"primaryCompletion":311,"completion":311,"start":312,"enrollment":313,"conditions":314,"interventions":317},"NCT06027151","Comparing the Efficacy of Metronidazole and Minocycline Gels for the Treatment of Diabetic Periodontitis Patients",[55],"2023-07-31","2022-10-06",380,[315,316],"Periodontitis","Diabetes Mellitus",[293,318,319],"1ml of 2% minocycline gel","1ml of combination of 1% metronidazole gel and 2% minocycline",{"intervention":318,"totalTrials":58,"cells":321},{"EARLY_PHASE1":322,"PHASE1":324,"PHASE2":326,"PHASE3":328,"PHASE4":330,"NA":332},{"trials":323,"activeCount":9},[],{"trials":325,"activeCount":9},[],{"trials":327,"activeCount":9},[],{"trials":329,"activeCount":9},[],{"trials":331,"activeCount":9},[],{"trials":333,"activeCount":9},[334],{"nctId":308,"briefTitle":309,"status":139,"phases":335,"primaryCompletion":311,"completion":311,"start":312,"enrollment":313,"conditions":336,"interventions":337},[55],[315,316],[293,318,319],{"intervention":319,"totalTrials":58,"cells":339},{"EARLY_PHASE1":340,"PHASE1":342,"PHASE2":344,"PHASE3":346,"PHASE4":348,"NA":350},{"trials":341,"activeCount":9},[],{"trials":343,"activeCount":9},[],{"trials":345,"activeCount":9},[],{"trials":347,"activeCount":9},[],{"trials":349,"activeCount":9},[],{"trials":351,"activeCount":9},[352],{"nctId":308,"briefTitle":309,"status":139,"phases":353,"primaryCompletion":311,"completion":311,"start":312,"enrollment":313,"conditions":354,"interventions":355},[55],[315,316],[293,318,319],{"intervention":357,"totalTrials":58,"cells":358},"Ibuprofen 400 mg",{"EARLY_PHASE1":359,"PHASE1":361,"PHASE2":363,"PHASE3":365,"PHASE4":367,"NA":369},{"trials":360,"activeCount":9},[],{"trials":362,"activeCount":9},[],{"trials":364,"activeCount":9},[],{"trials":366,"activeCount":9},[],{"trials":368,"activeCount":9},[],{"trials":370,"activeCount":9},[371],{"nctId":372,"briefTitle":373,"status":139,"phases":374,"primaryCompletion":311,"completion":311,"start":375,"enrollment":376,"conditions":377,"interventions":379},"NCT05983042","Effect of CYP2C9*3 Polymorphism on Ibuprofen in Pakistani Population",[],"2022-11-01",200,[378],"Healthy Volunteers",[357],{"intervention":381,"totalTrials":58,"cells":382},"Propofol",{"EARLY_PHASE1":383,"PHASE1":385,"PHASE2":387,"PHASE3":389,"PHASE4":391,"NA":393},{"trials":384,"activeCount":9},[],{"trials":386,"activeCount":9},[],{"trials":388,"activeCount":9},[],{"trials":390,"activeCount":9},[],{"trials":392,"activeCount":9},[],{"trials":394,"activeCount":9},[395],{"nctId":396,"briefTitle":397,"status":139,"phases":398,"primaryCompletion":399,"completion":400,"start":401,"enrollment":402,"conditions":403,"interventions":405},"NCT05383534","To Study the Pharmacokinetic and Cardiovascular Effects of Propofol With Respect to Pharmacogenetics in Pakistani Population",[],"2021-05-10","2022-04-14","2020-01-06",250,[404],"Healthy Volunteer",[381],{"intervention":407,"totalTrials":58,"cells":408},"Exer gaming",{"EARLY_PHASE1":409,"PHASE1":411,"PHASE2":413,"PHASE3":415,"PHASE4":417,"NA":419},{"trials":410,"activeCount":9},[],{"trials":412,"activeCount":9},[],{"trials":414,"activeCount":9},[],{"trials":416,"activeCount":9},[],{"trials":418,"activeCount":9},[],{"trials":420,"activeCount":9},[421],{"nctId":422,"briefTitle":423,"status":139,"phases":424,"primaryCompletion":425,"completion":426,"start":427,"enrollment":428,"conditions":429,"interventions":432},"NCT05043727","Effects of Exer Gaming on Balance and Gait in Parkinson's Patients",[55],"2020-04-06","2020-04-21","2019-10-06",16,[430,431],"Parkinson Disease","Balance",[407,433],"conventional treatment plan",{"intervention":433,"totalTrials":58,"cells":435},{"EARLY_PHASE1":436,"PHASE1":438,"PHASE2":440,"PHASE3":442,"PHASE4":444,"NA":446},{"trials":437,"activeCount":9},[],{"trials":439,"activeCount":9},[],{"trials":441,"activeCount":9},[],{"trials":443,"activeCount":9},[],{"trials":445,"activeCount":9},[],{"trials":447,"activeCount":9},[448],{"nctId":422,"briefTitle":423,"status":139,"phases":449,"primaryCompletion":425,"completion":426,"start":427,"enrollment":428,"conditions":450,"interventions":451},[55],[430,431],[407,433],{"intervention":453,"totalTrials":58,"cells":454},"Bilateral Arm Training",{"EARLY_PHASE1":455,"PHASE1":457,"PHASE2":459,"PHASE3":461,"PHASE4":463,"NA":465},{"trials":456,"activeCount":9},[],{"trials":458,"activeCount":9},[],{"trials":460,"activeCount":9},[],{"trials":462,"activeCount":9},[],{"trials":464,"activeCount":9},[],{"trials":466,"activeCount":9},[467],{"nctId":468,"briefTitle":469,"status":139,"phases":470,"primaryCompletion":471,"completion":472,"start":473,"enrollment":474,"conditions":475,"interventions":476},"NCT04556903","Effects of m CIMT and Bilateral Arm Training on Upper Extremity Chronic Stroke Patients",[55],"2019-12-15","2019-12-30","2019-06-15",42,[15],[453,477],"modified constrained induce movement therapy",{"intervention":477,"totalTrials":58,"cells":479},{"EARLY_PHASE1":480,"PHASE1":482,"PHASE2":484,"PHASE3":486,"PHASE4":488,"NA":490},{"trials":481,"activeCount":9},[],{"trials":483,"activeCount":9},[],{"trials":485,"activeCount":9},[],{"trials":487,"activeCount":9},[],{"trials":489,"activeCount":9},[],{"trials":491,"activeCount":9},[492],{"nctId":468,"briefTitle":469,"status":139,"phases":493,"primaryCompletion":471,"completion":472,"start":473,"enrollment":474,"conditions":494,"interventions":495},[55],[15],[453,477],{"intervention":497,"totalTrials":58,"cells":498},"Pizotifen",{"EARLY_PHASE1":499,"PHASE1":501,"PHASE2":503,"PHASE3":505,"PHASE4":507,"NA":509},{"trials":500,"activeCount":9},[],{"trials":502,"activeCount":9},[],{"trials":504,"activeCount":9},[],{"trials":506,"activeCount":9},[],{"trials":508,"activeCount":9},[],{"trials":510,"activeCount":9},[511],{"nctId":512,"briefTitle":513,"status":139,"phases":514,"primaryCompletion":515,"completion":516,"start":517,"enrollment":518,"conditions":519,"interventions":521},"NCT06500624","Comparative Efficacy of Escitalopram Monotherapy and Escitalopram in Adjuvant With Pizotifen in Depressive Disorder",[55],"2024-08-30","2024-09-30","2024-06-03",88,[520],"Depression",[497],{"intervention":224,"totalTrials":58,"cells":523},{"EARLY_PHASE1":524,"PHASE1":526,"PHASE2":528,"PHASE3":530,"PHASE4":532,"NA":534},{"trials":525,"activeCount":9},[],{"trials":527,"activeCount":9},[],{"trials":529,"activeCount":9},[],{"trials":531,"activeCount":9},[],{"trials":533,"activeCount":9},[],{"trials":535,"activeCount":9},[536],{"nctId":218,"briefTitle":219,"status":139,"phases":537,"primaryCompletion":210,"completion":211,"start":212,"enrollment":74,"conditions":538,"interventions":539},[55],[15,222],[224,192],{"intervention":541,"totalTrials":58,"cells":542},"plates based exercises",{"EARLY_PHASE1":543,"PHASE1":545,"PHASE2":547,"PHASE3":549,"PHASE4":551,"NA":553},{"trials":544,"activeCount":9},[],{"trials":546,"activeCount":9},[],{"trials":548,"activeCount":9},[],{"trials":550,"activeCount":9},[],{"trials":552,"activeCount":9},[],{"trials":554,"activeCount":9},[555],{"nctId":556,"briefTitle":557,"status":139,"phases":558,"primaryCompletion":210,"completion":211,"start":212,"enrollment":559,"conditions":560,"interventions":562},"NCT05021445","Effects of Pilates Exercises on Dynamic Balance in Elderly Population",[55],24,[561],"Elderly Population",[541,563],"conventional exercises",{"intervention":563,"totalTrials":58,"cells":565},{"EARLY_PHASE1":566,"PHASE1":568,"PHASE2":570,"PHASE3":572,"PHASE4":574,"NA":576},{"trials":567,"activeCount":9},[],{"trials":569,"activeCount":9},[],{"trials":571,"activeCount":9},[],{"trials":573,"activeCount":9},[],{"trials":575,"activeCount":9},[],{"trials":577,"activeCount":9},[578],{"nctId":556,"briefTitle":557,"status":139,"phases":579,"primaryCompletion":210,"completion":211,"start":212,"enrollment":559,"conditions":580,"interventions":581},[55],[561],[541,563],{"intervention":583,"totalTrials":58,"cells":584},"medication",{"EARLY_PHASE1":585,"PHASE1":587,"PHASE2":589,"PHASE3":591,"PHASE4":593,"NA":595},{"trials":586,"activeCount":9},[],{"trials":588,"activeCount":9},[],{"trials":590,"activeCount":9},[],{"trials":592,"activeCount":9},[],{"trials":594,"activeCount":9},[],{"trials":596,"activeCount":9},[597],{"nctId":598,"briefTitle":599,"status":600,"phases":601,"primaryCompletion":602,"completion":602,"start":603,"enrollment":22,"conditions":604,"interventions":606},"NCT06377826","Comparison of Aerobic and Resistance Training on Exercise Capacity, Depression and Quality of Life in Hypothyroidism.","UNKNOWN",[55],"2024-06-01","2024-04-01",[605],"Comparison of Aerobic Exercise and Resistance Training",[583],{"intervention":608,"totalTrials":58,"cells":609},"Atorvastatin 10mg",{"EARLY_PHASE1":610,"PHASE1":612,"PHASE2":614,"PHASE3":616,"PHASE4":618,"NA":620},{"trials":611,"activeCount":9},[],{"trials":613,"activeCount":9},[],{"trials":615,"activeCount":9},[],{"trials":617,"activeCount":9},[],{"trials":619,"activeCount":9},[],{"trials":621,"activeCount":9},[622],{"nctId":623,"briefTitle":624,"status":139,"phases":625,"primaryCompletion":626,"completion":627,"start":628,"enrollment":629,"conditions":630,"interventions":631},"NCT07578857","Combined Effects of Withania Somnifera & Syzgium Cumini on Hyperlipidemia",[55],"2023-10-10","2023-10-25","2023-05-24",60,[179],[608,632],"Group D",{"intervention":632,"totalTrials":58,"cells":634},{"EARLY_PHASE1":635,"PHASE1":637,"PHASE2":639,"PHASE3":641,"PHASE4":643,"NA":645},{"trials":636,"activeCount":9},[],{"trials":638,"activeCount":9},[],{"trials":640,"activeCount":9},[],{"trials":642,"activeCount":9},[],{"trials":644,"activeCount":9},[],{"trials":646,"activeCount":9},[647],{"nctId":623,"briefTitle":624,"status":139,"phases":648,"primaryCompletion":626,"completion":627,"start":628,"enrollment":629,"conditions":649,"interventions":650},[55],[179],[608,632],{"intervention":652,"totalTrials":58,"cells":653},"Valproic Acid",{"EARLY_PHASE1":654,"PHASE1":656,"PHASE2":658,"PHASE3":660,"PHASE4":662,"NA":664},{"trials":655,"activeCount":9},[],{"trials":657,"activeCount":9},[],{"trials":659,"activeCount":9},[],{"trials":661,"activeCount":9},[],{"trials":663,"activeCount":9},[],{"trials":665,"activeCount":9},[666],{"nctId":667,"briefTitle":668,"status":139,"phases":669,"primaryCompletion":185,"completion":186,"start":187,"enrollment":376,"conditions":670,"interventions":672},"NCT06674070","SCN2A Polymorphisms Are Associated With Response to Valproic Acid in Paediatric Population(Pakistan)",[],[671],"Epilepsy",[652]]